Tabata Y, Murakami Y, Ikada Y
Research Center for Biomedical Engineering, Kyoto University.
Jpn J Cancer Res. 1997 Nov;88(11):1108-16. doi: 10.1111/j.1349-7006.1997.tb00336.x.
Fullerence (C60) efficiently generates singlet oxygen when irradiated with light, and thus should have a photodynamic effect on tumors, if it is accumulated in the tumor tissue. To explore tumor targeting of C60, we chemically modified the water-insoluble C60 with polyethylene glycol (PEG), not only to make it soluble in water, but also to enlarge its molecular size. When injected intravenously into mice carrying a tumor mass in the back subcutis, the C60-PEG conjugate exhibited higher accumulation and more prolonged retention in the tumor tissue than in normal tissue. The conjugate was excreted without being accumulated in any specific organ. Following intravenous injection of C60-PEG conjugate or Photofrin to tumor-bearing mice, coupled with exposure of the tumor site to visible light, the volume increase of the tumor mass was suppressed and the C60 conjugate exhibited a stronger suppressive effect than Photofrin. Histological examination revealed that conjugate injection plus light irradiation strongly induced tumor necrosis without any damage to the overlying normal skin. The antitumor effect of the conjugate increased with increasing irradiation power and C60 dose, and cures were achieved by treatment with a dose of 424 micrograms/kg at an irradiation power of 107 J/cm2. These findings indicate that PEG-modified C60 is a candidate agent for photodynamic tumor therapy.
富勒烯(C60)在光照下能高效产生活性单线态氧,因此,如果它能在肿瘤组织中蓄积,就应对肿瘤产生光动力效应。为了探究C60的肿瘤靶向性,我们用聚乙二醇(PEG)对水不溶性的C60进行化学修饰,不仅使其能溶于水,还增大了其分子尺寸。当将C60 - PEG偶联物静脉注射到背部皮下携带肿瘤块的小鼠体内时,它在肿瘤组织中的蓄积量高于正常组织,且在肿瘤组织中的滞留时间更长。该偶联物可排出体外,不会在任何特定器官中蓄积。给荷瘤小鼠静脉注射C60 - PEG偶联物或光敏剂,再将肿瘤部位暴露于可见光下,肿瘤块的体积增大受到抑制,且C60偶联物的抑制作用比光敏剂更强。组织学检查显示,注射偶联物并进行光照强烈诱导肿瘤坏死,而对覆盖其上的正常皮肤无任何损伤。偶联物的抗肿瘤作用随照射功率和C60剂量的增加而增强,在照射功率为107 J/cm2时,用424微克/千克的剂量进行治疗可实现治愈。这些发现表明,PEG修饰的C60是光动力肿瘤治疗的候选药物。